CII
QGENF

CR Intrinsic Investors’s QIAGEN NV QGENF Stock Holding History

CR Intrinsic Investors’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-125,740
Closed -$2.5M – 478
2013
Q2 		$2.5M Buy
+125,740
New +$2.5M 0.09% 249

Other funds holding QGENF

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

CR Intrinsic Investors's QGENF Position: Q3 2013 in Review

CR Intrinsic Investors sold out of QIAGEN NV (QGENF) in Q3 2013, closing a stake of 125,740 shares — an estimated $2.5M sold.

CR Intrinsic Investors first reported a position in QGENF in Q2 2013 and held it in 1 quarter. The position peaked at $2.5M in Q2 2013. 150 funds tracked by Wall St. Rank hold QGENF as of Q3 2013.

  • CR Intrinsic Investors reported no remaining QIAGEN NV position as of Q3 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 125,740 QIAGEN NV shares in Q3 2013, an estimated $2.5M.
  • CR Intrinsic Investors first reported a position in QIAGEN NV in Q2 2013 and held it in 1 quarter.
  • CR Intrinsic Investors's QIAGEN NV position peaked at $2.5M in Q2 2013.
  • 150 funds tracked by Wall St. Rank held QIAGEN NV as of Q3 2013.

Based on CR Intrinsic Investors's 13F filing for Q3 2013, filed 14 Nov 2013.